Reactions Weekly

, Volume 1697, Issue 1, pp 177–177 | Cite as

Gemcitabine

Acquired resistance in pancreatic ductal adenocarcinoma: case report
Case report
  • 15 Downloads

Reference

  1. Nishimura A, et al. Gemcitabine enhances KRAS-MEK-induced matrix metalloproteinase-10 expression in gemcitabine-resistant pancreatic tumor-initiating cells. Pancreas 46: 1423, No. 10, Jan 2017 [abstract] - JapanGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations